1810011o10 Rik Inhibits the Antitumor Effect of Intratumoral CD8+ T Cells through Suppression of Notch2 Pathway in a Murine Hepatocellular Carcinoma Model
Kai Dai(Renmin Hospital of Wuhan University), Yingan Jiang(Wuhan University)
Cited by 11
Related Papers
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
|Journal of Hepatology|2021|118
Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
|Frontiers in Pharmacology|2021|24